Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
- DOI
- 10.3390/biom12060784
- Published
- 2022-06-04
- Container
- Biomolecules
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/biom12060784,
title = {Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges},
author = {Francisco Rodríguez and Pablo Caruana and Noa De la Fuente and Pía Español and María Gámez and Josep Balart and Elisa Llurba and Ramón Rovira and Raúl Ruiz and Cristina Martín-Lorente and José Luis Corchero and María Virtudes Céspedes},
year = {2022},
journal = {Biomolecules},
doi = {10.3390/biom12060784},
url = {https://doi.org/10.3390/biom12060784}
}RIS
TY - JOUR TI - Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges AU - Francisco Rodríguez AU - Pablo Caruana AU - Noa De la Fuente AU - Pía Español AU - María Gámez AU - Josep Balart AU - Elisa Llurba AU - Ramón Rovira AU - Raúl Ruiz AU - Cristina Martín-Lorente AU - José Luis Corchero AU - María Virtudes Céspedes PY - 2022 JO - Biomolecules DO - 10.3390/biom12060784 UR - https://doi.org/10.3390/biom12060784 ER -
APA
Rodríguez, F., Caruana, P., Fuente, N. D. L., Español, P., Gámez, M., Balart, J., Llurba, E., Rovira, R., Ruiz, R., Martín-Lorente, C., Corchero, J. L., & Céspedes, M. V. (2022). Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges. Biomolecules. https://doi.org/10.3390/biom12060784
Source records
- crossref · retrieved 2026-09-26T17:04:20.502Z